Does SARILUMAB Cause Injection site dryness? 29 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 29 reports of Injection site dryness have been filed in association with SARILUMAB (KEVZARA). This represents 0.1% of all adverse event reports for SARILUMAB.
29
Reports of Injection site dryness with SARILUMAB
0.1%
of all SARILUMAB reports
0
Deaths
1
Hospitalizations
How Dangerous Is Injection site dryness From SARILUMAB?
Of the 29 reports, 1 (3.4%) required hospitalization.
Is Injection site dryness Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SARILUMAB. However, 29 reports have been filed with the FAERS database.
What Other Side Effects Does SARILUMAB Cause?
Drug ineffective (5,065)
Pain (4,833)
Arthralgia (4,139)
Rheumatoid arthritis (3,963)
Joint swelling (3,951)
Condition aggravated (3,247)
Fatigue (3,000)
Rash (2,912)
Alopecia (2,660)
Abdominal discomfort (2,600)
What Other Drugs Cause Injection site dryness?
DUPILUMAB (320)
ETANERCEPT (37)
ADALIMUMAB (31)
BELIMUMAB (21)
PEGINTERFERON BETA-1A (21)
TREPROSTINIL (16)
ALIROCUMAB (14)
GLATIRAMER (13)
INTERFERON BETA-1A (13)
TIRZEPATIDE (12)
Which SARILUMAB Alternatives Have Lower Injection site dryness Risk?
SARILUMAB vs SATRALIZUMAB
SARILUMAB vs SATRALIZUMAB-MWGE
SARILUMAB vs SAXAGLIPTIN
SARILUMAB vs SCHOLL'S INGROWN TOENAIL PAIN RELIEVER
SARILUMAB vs SCOPOLAMINE